MST1R and myeloproliferative disorder: However, the role of RON kinase, a member of MET kinase family, is unknown in MPN pathogenesis, the RON phosphorylation was found enhanced in JAK inhibitor persistent cells, suggesting RON inhibitor as a suitable target agent in MPN patients [134].